The global cystic fibrosis devices market is currently valued at US$ 825.09 million and is expected to increase at a massive CAGR of 10% from 2023 to 2033 and is projected to reach US$ 2.14 billion by 2033. A hereditary condition brought on by gene mutations is known as cystic fibrosis (CF). The lungs, digestive system, and other body organs are severely damaged by the genetic illness...